Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration.

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration.

To investigate the prevalence and genetic characteristics of geographic atrophy (GA) among elderly Japanese with advanced age-related macular degeneration (AMD) in a clinic-based study.Two-hundred and ninety consecutive patients with advanced AMD were classified into typical neovascular AMD, polypoi...

Full description

Bibliographic Details
Main Authors:	Yoichi Sakurada, Seigo Yoneyama, Atsushi Sugiyama, Naohiko Tanabe, Wataru Kikushima, Fumihiko Mabuchi, Atsuki Kume, Takeo Kubota, Hiroyuki Iijima
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4769020?pdf=render

Similar Items

Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration
by: Taiyo Shijo, et al.
Published: (2020-09-01)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
by: Wataru Kikushima, et al.
Published: (2021-03-01)

Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2020-07-01)

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Wataru Kikushima, et al.
Published: (2020-01-01)

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Kikushima Wataru, et al.
Published: (2020-01-01)

Systemic expression of Alu RNA in patients with geographic atrophy secondary to age-related macular degeneration.
by: Hiroyuki Yoshida, et al.
Published: (2019-01-01)

Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review
by: Malvika Arya, et al.
Published: (2018-09-01)

Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration.
by: Kameran Lashkari, et al.
Published: (2020-01-01)

Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.
by: Felix Grassmann, et al.
Published: (2015-01-01)

Photoreceptor Damage and Reduction of Retinal Sensitivity Surrounding Geographic Atrophy in Age-Related Macular Degeneration
by: Takahashi, Ayako
Published: (2018)

Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study
by: José M. Ruiz-Moreno, et al.
Published: (2020-01-01)

Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects
by: Danis RP, et al.
Published: (2015-11-01)

Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions
by: Tiarnan D.L. Keenan, BM BCh, PhD
Published: (2021-12-01)

Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Correlation with Macular Function
by: Maria C. Savastano, et al.
Published: (2020-09-01)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
by: Omar A. Halawa, et al.
Published: (2021-06-01)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2021-09-01)

Analyzing Age-Related Macular Degeneration Progression in Patients with Geographic Atrophy Using Joint Autoencoders for Unsupervised Change Detection
by: Guillaume Dupont, et al.
Published: (2020-06-01)

Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy
by: Miguel Hage Amaro, et al.
Published: (2012-08-01)

Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
by: Marcella Nebbioso, et al.
Published: (2019-04-01)

Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy
by: Waheed, Nadia K., et al.
Published: (2017)

Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus
by: Atsuki Kume, et al.
Published: (2020-07-01)

Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics
by: Taiyo Shijo, et al.
Published: (2021-04-01)

Challenges in studying geographic atrophy (GA) age-related macular degeneration: the potential of a new mouse model with GA-like features
by: J Arjuna Ratnayaka, et al.
Published: (2020-01-01)

A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration
by: Kenji Yamashiro, et al.
Published: (2017-08-01)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
by: Pukhraj Rishi, et al.
Published: (2011-02-01)

Age-related macular degeneration with choroidal neovascularization in the setting of pre-existing geographic atrophy and ranibizumab treatment. Analysis of a case series and revision paper
by: Miguel Hage Amaro, et al.
Published: (2012-12-01)

Macrophages and Macular Degeneration
by: Martine J Jager
Published: (2014-01-01)

Macular atrophy and Zika virus infection
by: Beuy Joob, et al.

Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration.
by: Victor A Eng, et al.
Published: (2020-01-01)

Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen
by: Hiroyuki Kamao, et al.
Published: (2021-01-01)

Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO)
by: Bindewald A, et al.
Published: (2005-04-01)

Progression of Atrophy and Visual Outcomes in Extensive Macular Atrophy with Pseudodrusen-like Appearance
by: Francesco Romano, MD, et al.
Published: (2021-03-01)

Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part I: A Review of Disease Characterization and Morphological Associations
by: Mania Horani, et al.
Published: (2019-03-01)

Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year
by: Sumit Randhir Singh, et al.
Published: (2020-01-01)

Age-related macular degeneration
by: Wanjiku Mathenge
Published: (2014-12-01)

Immunological status of macular degeneration
by: Gupta G, et al.
Published: (1983-01-01)

Age-related macular degeneration
by: Querques G, et al.
Published: (2011-05-01)

PHOTODYNAMIC THERAPY OF MACULAR DEGENERATION
by: Davorin Sevšek, et al.
Published: (2004-05-01)

Medullary microvessel degeneration in multiple system atrophy
by: V.M. Miller, et al.
Published: (2007-06-01)

Dietary, environmental, and genetic risk factors of Extensive Macular Atrophy with Pseudodrusen, a severe bilateral macular atrophy of middle-aged patients
by: Aymeric Douillard, et al.
Published: (2018-05-01)